skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Tuesday, June 12, 2012

Another Free GMP Glossary

Here's another free GMP glossary.

Free cGMP Glossary by Contract Pharma - 'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Related articles

  • The Best GMP Training - Look No Further! (skillsplusinfo.blogspot.com)
  • Essentials for Pharmaceutical Manufacturers - Live onsite cGMP training (skillsplusinfo.blogspot.com)
  • Onsite cGMP Training - Olympics for Pharmaceutical & Biotech Manufacturers (skillsplusinfo.blogspot.com)

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 7:50 AM
Labels: cgmp, classes, courses, definitions, dictionary, fda, free, glossary, gmp, information, resources, terms, training

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

  • Popular cGMP Online Training Courses Updated
  • As Supply Chain Partners Ramp Up For November DSCSA Deadline, US FDA Gives Them Another Year - Pink Sheet
  • California Designated Representative 3PL Training Course
  • DRUG FRAUD ALERT: DISTRIBUTOR/CUSTOMER PRODUCT ORDERING SCHEME
  • Drug Products, Including Biological Products, that Contain Nanomaterials - Final Guidance Document
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • FierceBiotech
    Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
    23 minutes ago
  • Science-Based Medicine
    “Make America Healthy Again”: The new Lysenkoism
    1 hour ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about fallout over ousted FDA official, a Colorado pharma setback, and more
    1 hour ago
  • eLearning Industry
    How To Write A Follow-Up Email After No Response: Tips And Examples That Get Replies
    1 hour ago
  • Medscape Today Headlines
    French Agency Seeks Endocrine Disruptor Label for Resorcinol
    3 hours ago
  • GEN Biotech News
    RNAi Therapeutic for Hemophilia A or B Gets FDA Approval
    4 hours ago
  • Drug Channels
    The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments
    4 hours ago
  • Pharmaceutical Commerce
    Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more
    4 hours ago
  • Modern Healthcare News
    Healthcare sector shaken as Trump stirs havoc in D.C.
    4 hours ago
  • NPR Blogs: Shots - Health News Blog
    How much will that surgery cost? Hospital price lists remain largely unhelpful
    4 hours ago
  • Wellness Blog - NY Times
    People Are Promoting Ivermectin for Cancer. Here’s What to Know.
    5 hours ago
  • BioPharma Dive - Latest News
    How discoverable, comparable and explorable is your data?
    5 hours ago
  • Drug & Device Law
    Muldoon Dismissed – The End of an Error?
    5 hours ago
  • All Kaiser Health News
    Readers Shop for Nutritional Information and Weigh Radiation and Cancer Risks
    5 hours ago
  • BioPharma Dive
    How discoverable, comparable and explorable is your data?
    5 hours ago
  • Medtech Insight
    How Cutting Edge Technology Is Changing Risk Management In the EU
    5 hours ago
  • Government Executive
    With RIFs imminent, the Small Business Administration reoffers its Deferred Resignation Program
    13 hours ago
  • CNBC Health Care
    23andMe bankruptcy: With America's DNA put on sale, market panic gets a new twist
    23 hours ago
  • Mobihealthnews
    Elon Musk's Neuralink files to trademark 'Blindsight,' 'Telepathy,' and 'Telekinesis'
    2 days ago
  • JD Supra Law News
    Key Takeaways From the Copyright Office's Report on the Economic Impact of AI
    2 days ago
  • FDA What's New: Drugs
    FDA approves durvalumab for muscle invasive bladder cancer
    2 days ago
  • FDA - Press Releases
    FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
    2 days ago
  • Pharmafile
    FDA grants fast track designation to chlamydia vaccine candidate
    2 days ago
  • Clarkston Consulting
    Leveraging Metric Trees for Retail Analytics
    3 days ago
  • FierceBiotech: Medtech
    Exact Sciences kicks off commercial launch of next-gen Cologuard Plus cancer test
    3 days ago
  • World Pharma - Breaking News
    Preclinical study: after heart attack, a boost in anti-inflammatory cells promoted healing
    3 days ago
  • FiercePharma
    "Drug loss" opens the door even further for the Japanese market entry
    4 days ago
  • Pharmafile - Mfg & Production
    Cold Chain Technologies acquires Global Cold Chain Solutions
    4 days ago
  • Clinical Correlations
    A Brief History of Insulin and Type 1 Diabetes
    6 days ago
  • The Incidental Economist
    An Opportunity: Philanthropy Can Reshape Drug Innovation
    1 week ago
  • Marler Blog
    FDA again kicks the Food Traceability Rule down the Road
    1 week ago
  • Food Poison Journal
    Salmonella Outbreak tied to Pastries over
    1 week ago
  • Healthcare Packaging
    Streamlining Prefilled Syringe Use for Adrenal Crisis Patients
    1 week ago
  • Asbestos and Mesothelioma News
    From Toxic Pile to Carbon Sponge: Asbestos Mine Gets a Green Makeover
    1 week ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    3 weeks ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    5 weeks ago
  • Quality Matters
    India and the United States manufacture most finished medicines for the U.S. market
    5 weeks ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    2 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    2 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    2 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    2 months ago
  • Designated Representative and Exemptee
    Exemptee Training | Designated Representative Training
    2 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    3 months ago
  • The Compliance and Ethics Blog
    Bob Wade on Fair Market Value in Healthcare [Podcast]
    5 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    6 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Combined vaping & smoking increases lung cancer risk
    7 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    7 months ago
  • SkillsPlus International Info
    Popular cGMP Online Training Courses Updated
    8 months ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    1 year ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    1 year ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Ted Eytan, MD
    Recipe: Keto Peanut Butter Pie
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    2 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    2 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ▼  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ▼  June (23)
      • FDA Consumer Updates - Beware of Online Cancer Fraud
      • Congress To FDA: Study Nano Safety
      • Court Ruling Lets $813 Billion in Higher Taxes Pro...
      • FAQs: Your Sunscreen Questions. EWG Answers
      • New FDA sunscreen label standards delayed until wi...
      • FDA regulators face daunting task as health apps m...
      • The Cost of Quality Failures - An FDA Response
      • Warning: Your “Check CAPA” Light is On - FDA Form 483
      • FDA Warning Letter Analysis: Supplement Manufactur...
      • The Best Drug Companies Of The Past 15 Years
      • FDA releases nutritional guide to insects, vermin ...
      • Reagan-Udall Foundation Receives FDA Funding to Ad...
      • Another Free GMP Glossary
      • P.R. China - Good Manufacturing Practice for Drugs...
      • FDA delays decision on drug to prevent HIV
      • New Wave of Cancer Combo Drugs Coming With Fewer S...
      • FDA Form 483 Can Form Basis of Class Action Lawsuit
      • How Human Factors Lead to Medical Device Adverse E...
      • What is GMP for Dietary Supplements - Free Video
      • Top 10 Ways to Make GMP Training Relevant
      • The FDA should have the power to go after counterf...
      • FDA and ISMP working together help consumers preve...
      • 5/29/12 - Warning Letter Analysis: Device Companie...
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo